Clostridium strains selected from human stool samples modulate intestinal susceptibility and immune activity to IBD by inhibiting immune‐mediated NF‐κB activation in intestinal epithelial organoids derived from IBD patients.110. Here, NFKB1 is linked to inflammatory bowel disease.